INSIDE TRACK: NGS Takes the Big Leap
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
Read MorePosted by Jenny Lower | Jan 3, 2014 | Cancer, Molecular Diagnostics |
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
Read MorePosted by Steve Halasey | Dec 3, 2013 | Molecular Diagnostics |
With a new $20 million bankroll, Xagenic Inc, Toronto, says it’s on the way to developing a rapid, point-of-care molecular diagnostics platform suitable for use in physician offices and clinics.
Read MorePosted by Judy O'Rourke | Oct 29, 2013 | Sexually Transmitted Diseases |
Alere Determine HIV 1/2 Ag/Ab Combo can detect HIV earlier than second- and third-generation antibody-only tests.
Read MorePosted by Judy O'Rourke | Oct 23, 2013 | Infectious Diseases |
New law requires health service providers to offer a one-time hepatitis C test to people born between 1945 and 1965.
Read MorePosted by Judy O'Rourke | Oct 4, 2013 | Uncategorized |
A range of products to explore, from bioMerieux’s new clinical mass spec MALDI-TOF-based system to new genetic tests for cancer, to bins to keep everything in its place.
Read More